Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Black cohosh (Cimicifuga racemosa) contains triterpene glycosides that modulate hormonal activity through LH suppression and opioid receptor activation. This herb primarily targets menopausal symptoms, particularly hot flashes and mood disturbances.
Origin & History
Black cohosh (Cimicifuga racemosa) is a perennial plant native to North America, belonging to the buttercup family. The medicinal portions are derived from the plant's roots and rhizomes, typically extracted using 70% ethanol or methanol and standardized to triterpene glycosides content.
Research Narrative (Provisional)
The research dossier indicates a notable absence of specific human clinical trials, RCTs, or meta-analyses with PubMed PMIDs. While black cohosh is commonly studied for menopausal symptoms and some extracts have shown LH suppression in menopausal women and ovariectomized rats, the active constituents and mechanisms remain undetermined.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Black Cohosh (Cimicifuga racemosa) rhizome and root contain negligible macronutrients in typical therapeutic doses (300–500 mg standardized extract). Primary bioactive compounds include: Triterpene glycosides (actein, 23-epi-26-deoxyactein, cimicifugoside) at approximately 2–3% dry weight concentration, standardized in commercial extracts to 2.5% triterpene glycosides calculated as 27-deoxyactein. Phenolic compounds include caffeic acid derivatives (fukinolic acid, cimicifugic acids A–H) at roughly 0.1–0.5% dry weight, and isoferulic acid. Flavonoids (formononetin historically reported but largely absent or trace-level in most chemotype analyses, <0.005%). Cycloartane-type triterpenes constitute the principal pharmacologically active fraction. Alkaloids include N-methylcytisine and related quinolizidine alkaloids at trace concentrations (<0.01%). Tannins and resins contribute to approximately 15–20% of crude rhizome extract by weight. Volatile oils present at <1% include salicylic acid precursors. Starch and polysaccharides represent the bulk non-active fraction (~40–50% crude rhizome). Bioavailability data is limited; triterpene glycosides undergo intestinal hydrolysis releasing aglycone forms (e.g., actein) which are preferentially absorbed; first-pass hepatic metabolism is significant. No clinically meaningful vitamin, mineral, or dietary fiber content is delivered at standard therapeutic doses.
Reported Mechanism (Provisional)
Black cohosh's triterpene glycosides, particularly actein and cimicifugoside, suppress luteinizing hormone (LH) release from the anterior pituitary. The extract also binds to μ-opioid receptors in the brain, potentially modulating temperature regulation and pain perception. Additional anti-inflammatory effects occur through nitric oxide inhibition in microglial cells.
Clinical Narrative (Provisional)
Preliminary animal studies demonstrate LH suppression, while in-vitro research shows μ-opioid receptor binding activity. Limited human trials suggest modest improvements in hot flash frequency and intensity, though sample sizes remain small (typically 50-200 participants). Current evidence is primarily preclinical, with human studies showing mixed results and requiring larger, longer-duration trials for definitive conclusions.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.